Y-MABS THERAPEUTICS INC

CUSIP: 984241109 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 207,642 Value ($000) $936 Avg Close — Range —
Q1 2025
Shares 153,955 Value ($000) $682 Avg Close — Range —
Q4 2024
Shares 221,914 Value ($000) $1,738 Avg Close — Range —
Q3 2024
Shares 274,547 Value ($000) $3,610 Avg Close — Range —
Q2 2024
Shares 261,744 Value ($000) $3,162 Avg Close — Range —
Q1 2024
Shares 118,301 Value ($000) $1,924 Avg Close — Range —
Q4 2023
Shares 137,500 Value ($000) $938 Avg Close — Range —
Q3 2023
Shares 414,307 Value ($000) $2,258 Avg Close — Range —
Q2 2023
Shares 31,513 Value ($000) $214 Avg Close — Range —
Q1 2023
Shares 305,710 Value ($000) $1,532 Avg Close — Range —
Q4 2022
Shares 960,421 Value ($000) $4,687 Avg Close — Range —
Q3 2022
Shares 90,460 Value ($000) $1,304 Avg Close — Range —
Q1 2022
Shares 26,927 Value ($000) $320 Avg Close — Range —
Q4 2021
Shares 125,698 Value ($000) $2,038 Avg Close — Range —
Q3 2021
Shares 104,515 Value ($000) $2,983 Avg Close — Range —
Q2 2021
Shares 175,185 Value ($000) $5,921 Avg Close — Range —
Q1 2021
Shares 91,395 Value ($000) $2,764 Avg Close — Range —
Q4 2020
Shares 115,469 Value ($000) $5,717 Avg Close — Range —
Q3 2020
Shares 9,168 Value ($000) $352 Avg Close — Range —
Q2 2020
Shares 13,000 Value ($000) $561 Avg Close — Range —
Q1 2020
Shares 37,913 Value ($000) $990 Avg Close — Range —
Q4 2019
Shares 70,328 Value ($000) $2,197 Avg Close — Range —